SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-16-651240
Filing Date
2016-07-19
Accepted
2016-07-19 16:45:06
Documents
8

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 d207633ds3a.htm S-3/A 400500
2 EX-23.1 d207633dex231.htm EX-23.1 1830
3 EX-23.2 d207633dex232.htm EX-23.2 1685
5 GRAPHIC g207633g08c20.jpg GRAPHIC 36896
6 GRAPHIC g207633g32n73.jpg GRAPHIC 33246
7 GRAPHIC g207633g59n40.jpg GRAPHIC 37770
8 GRAPHIC g207633g66z82.jpg GRAPHIC 3457
9 filename9.htm CORRESP 11470
  Complete submission text file 0001193125-16-651240.txt   570448
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-212114 | Film No.: 161773874
SIC: 2836 Biological Products, (No Diagnostic Substances)